← Back to Bozicevic, Field & Francis LLP
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19540475 | Immunoassays for Buprenorphine and Metabolites | Ark Diagnostics, Inc. | HAQ, SHAFIQUL | 1678 | §103§112 | Final Rejection | — | Pending | Feb 13, 2026 |
| 19372053 | Compositions, Devices, Systems, and Methods for Using a Nanopore | The Regents of the University of California | BRAZIN, JACQUELINE | 1798 | §103 | Final Rejection | — | Pending | Oct 28, 2025 |
| 18993797 | Methods and Systems for Detecting Stroke | The Regents of the University of California | UCHITEL, EMILY RUTH ABIGAIL | §101§103§112 | Non-Final OA | — | Pending | Jan 13, 2025 | |
| 18871774 | Motion Capture and Biomechanical Assessment of Goal-Directed Movements | The Regents of the University of California | COOPER, JONATHAN EPHRAIM | 3791 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18942149 | Promoting Hair Growth and Treatment of Hair Loss or Excessive Hair Shedding | Samson Clinical Pty Ltd. | CABRAL, ROBERT S | 1614 | §103 | Non-Final OA | — | Pending | Nov 08, 2024 |
| 18930210 | COMPOSITIONS AND METHODS FOR PRODUCING PRIMORDIAL GERM CELL-LIKE CELLS | Glaxosmithkline Intellectual Property Development Limited | KIM, TAEYOON | §102§103§112 | Non-Final OA | — | Pending | Oct 29, 2024 | |
| 18857803 | MESENCEPHALIC ASTROCYTE-DERIVED NEUROTROPHIC FACTOR (MANF) FOR INCREASING MUSCLE REGENERATION | Gulbenkian Institute For Molecular Medicine | CANDELARIA, JULIANA IRENE | 1634 | §102§112 | Non-Final OA | — | Pending | Oct 17, 2024 |
| 18912410 | METHODS OF TREATING EGFRVIII EXPRESSING GLIOBLASTOMAS | The Regents of the University of California | TIWARI, VYOMA SHUBHAM | 1634 | §112 | Final Rejection | — | Pending | Oct 10, 2024 |
| 18903947 | T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | ESPINOSA, CLAUDIA EDILMA | 1654 | §103§112Other | Non-Final OA | — | Pending | Oct 01, 2024 |
| 18890620 | TSPO Binders | The University Court of the University of Edinburgh | DONOHUE, SEAN R | 1618 | §102§103 | Final Rejection | — | Pending | Sep 19, 2024 |
| 18843688 | COMPOUNDS AND THEIR USES AS LPAR5 ANTAGONISTS | Immunophage Biotech (Shanghai) Co., Ltd. | ROCHELLE, CIERRA MARIE | 1627 | §103§112 | Non-Final OA | — | Pending | Sep 03, 2024 |
| 18806599 | Bacteria-Based Protein Delivery | Universitaet Basel | AMICK, THOMAS RUSSE | §102Other | Non-Final OA | — | Pending | Aug 15, 2024 | |
| 18729383 | A Machine Learning Pipeline for Highly-Sensitive Assessment of Rotator Cuff Function | The Regents of the University of California | KRETZER, KYLE W. | 3791 | §101§103§112 | Final Rejection | — | Pending | Jul 16, 2024 |
| 18725112 | Application of Polypeptide in Preparation of Product for Preventing or Treating Skin Injury Diseases | Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd. | KATAKAM, SUDHAKAR | 1658 | §112DP | Non-Final OA | — | Pending | Jun 27, 2024 |
| 18719710 | NOVEL SALT OF 1-SULFONYL PYRROLE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Ildong Pharmaceutical Co., Ltd. | JAVANMARD, SAHAR | 1622 | §102§103§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18716761 | CLOSO-DODECAIODODECABORATE COMPLEXES AND METHODS OF USE FOR SAME | The Regents of the University of California | JONES, DAMERON LEVEST | 1618 | §103§112 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18716045 | An Automated Process for Optimizing Spinal Cord Stimulation | The Regents of the University of California | COLLARD JR, DWANE EDWARD | 3792 | §102§103§112 | Non-Final OA | — | Pending | Jun 03, 2024 |
| 18658264 | Methods for Representing Data Analysis and Systems for Same | The Regents of the University of California | SILVERMAN, SETH ADAM | 2172 | §103 | Final Rejection | 12d | Pending | May 08, 2024 |
| 18657366 | Methods of Producing Size-Selected Nucleic Acid Libraries and Compositions and Kits for Practicing Same | The Regents of the University of California | BUNKER, AMY M | 1684 | §103§112 | Non-Final OA | — | Pending | May 07, 2024 |
| 18653683 | MULTIMERIC T-CELL MODULATORY POLYPEPTIDES AND METHODS OF USE THEREOF | Cue Biopharma, Inc. | ZOU, NIANXIANG | 1671 | §103§112DP | Non-Final OA | — | Pending | May 02, 2024 |
| 18650535 | Anti-Abeta Therapeutic Vaccines | Ac Immune SA | KIM, YUNSOO | 1641 | §102§103§112Other | Non-Final OA | — | Pending | Apr 30, 2024 |
| 18649688 | CRY PROTEIN CRYSTALS AND METHODS OF USE | BATTELLE MEMORIAL INSTITUTE | JOHNSON, TIRONE DEREK | 1675 | §102§103 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18703256 | Coxsackievirus B Compositions and Methods Of Use Thereof | Vactech OY | SIFFORD, JEFFREY MARK | 1671 | §101§103§112 | Non-Final OA | — | Pending | Apr 19, 2024 |
| 18702756 | Wearable Non-Invasive Central Nervous System Neuromodulator and Methods for Using Same | Spinex Inc. | KOWALKOWSKI, FIONA MARGARET | 3792 | §102§103 | Non-Final OA | 2d overdue | Pending | Apr 18, 2024 |
| 18696922 | Anti-Human Astrovirus Antibodies and Related Compositions and Methods | Universidad Nacional Autónoma De México | NICKOL, GARY B | 1643 | §102§103§112 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18690688 | Lithium Sulfur Cell | Cambridge Enterprise Limited | D'ANIELLO, NICHOLAS P | 1725 | §102§112 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18690533 | Suppression of Neurodegeneration with Zinc Transporter Protein 7 | The Regents of the University of California | CESARE, JOSEPH DAVID | 1675 | §103§112 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18688602 | STEROL THERAPY | Jena University Hospital | KIM, SEONG JONG | 1623 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18682740 | Vaccine Antigen | Macfarlane Burnet Institute For Medical Research And Public Health Limited | CHESTNUT, BARRY A | 1672 | §102§112 | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18418050 | MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES | Vactech OY | CHEN, STACY BROWN | 1672 | §112 | Final Rejection | 11d overdue | Pending | Jan 19, 2024 |
| 18580141 | USE OF A STROMAL ANTIGEN TO DELIVER CELL-BASED CANCER THERAPY TO A SOLID TUMOR | The Regents of the University of California | ABEYRATNE-PERERA, HASHANTHI KOMITIGE | §102§112 | Non-Final OA | — | Pending | Jan 17, 2024 | |
| 18579775 | A Surface Audio-Visual Biofeedback (SAVB) System for Motion Management | The Board Of Trustees Of The Leland Stanford Junior University | HON, MING Y | 2666 | §103 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18578617 | Compounds for Modulating Epithelial 15-(S)-Lipoxygenase-2 and Methods of Use for Same | The Regents of the University of California | KUCKLA, ANNA GRACE | 1626 | §103§112 | Final Rejection | — | Pending | Jan 11, 2024 |
| 18391501 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | The Governors of the University of Alberta | FOLEY, SHANON A | 1671 | §103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18544206 | Method of Neural Intervention for the Treatment of Affective Neuropsychiatric Disorders | The Regents of the University of California | EDWARDS, PHILIP CHARLES | 3792 | §103 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18570390 | Rippled Antiparallel Cross-Beta Dimers and Related Materials, Compositions and Methods | The Regents of the University of California | KOMATSU, LI N | 1658 | §102§112 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18568243 | Treatment or Prevention of Ischaemia Reperfusion Injury | Cambridge Enterprise Limited | NEAGU, IRINA | 1629 | §103DP | Final Rejection | — | Pending | Dec 07, 2023 |
| 18529858 | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF | The Governors of the University of Alberta | JADHAO, SAMADHAN JAISING | 1672 | §103§112DP | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18523548 | Compounds and Methods for Use in Detecting Gabapentin | Ark Diagnostics, Inc. | HAQ, SHAFIQUL | 1678 | §103§112DP | Non-Final OA | — | Pending | Nov 29, 2023 |
| 18565049 | Polymeric Antifouling Coating with Antimicrobial Peptides | The University of British Columbia | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §102§103 | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18520057 | E1E2 HCV VACCINES AND METHODS OF USE | The Governors of the University of Alberta | ZOU, NIANXIANG | 1671 | §103 | Final Rejection | — | Pending | Nov 27, 2023 |
| 18561981 | Methods And Devices For Real-Time Word And Speech Decoding From Neural Activity | The Regents of the University of California | PADDA, ARI SINGH KANE | 3791 | §101§103§112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18288793 | COMPOUNDS AND THEIR USES AS CD38 INHIBITORS | Nanjing Immunophage Biotech Co., Ltd. | LEE, ANDREW P | 1691 | §112 | Non-Final OA | — | Pending | Oct 27, 2023 |
| 18288545 | Linear DNA with Enhanced Resistance Against Exonucleases | 4Basebio UK Ltd. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §101§103§112Other | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18384266 | WATER DISPERSIBLE GRANULE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | Texas Crop Science, Inc. | VIGIL, TORIANA NICHOLE | 1612 | §103 | Final Rejection | — | Pending | Oct 26, 2023 |
| 18382419 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | Texas Crop Science, Inc. | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103§112DP | Final Rejection | 113d overdue | Pending | Oct 20, 2023 |
| 18287604 | Thermally Stable Lipid-Nucleic Acid Molecule Formulations Utilising Metal Organic Framework (MOF) Shells | Commonwealth Scientific And Industrial Research Organisation | ARNOLD, ERNST V | 1613 | §103DP | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18287094 | Closed-Loop Neuromodulation for the Treatment of Affective Neuropsychiatric Disorders | The Regents of the University of California | MARLEN, TAMMIE K | 3792 | §103 | Final Rejection | — | Pending | Oct 16, 2023 |
| 18551553 | Pharmaceutical Combinations for Treating Cancer | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | DRISCOLL, MAUREEN VARINA | 1644 | §112DP | Final Rejection | — | Pending | Sep 20, 2023 |
| 18468639 | METHOD FOR DETECTING NEUROLOGICAL DISEASES USING SUPRAMOLECULE POLYMER THERAPEUTICS | The Regents of the University of California | ESSEX, LAURA ANN | 1675 | §112DP | Final Rejection | — | Pending | Sep 15, 2023 |
| 18468633 | SUPRAMOLECULAR POLYMER THERAPEUTICS AND DIAGNOSTICS | The Regents of the University of California | ESSEX, LAURA ANN | 1675 | §112DP | Final Rejection | — | Pending | Sep 15, 2023 |
| 18276834 | Endometriosis-Related Methods and Compositions | The Regents of the University of California | AL-AWADI, DANAH J | 1615 | §103 | Final Rejection | — | Pending | Aug 10, 2023 |
| 18276848 | RNA Trans-Splicing Molecule | Cambridge Enterprise Limited | TRAN, CHRISTINA L | 1637 | §103§112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18275170 | Methods for Pulmonary Function Testing With Machine Learning Analysis and Systems for Same | The Regents of the University of California | HANEY, JONATHAN MICHAEL | 3791 | §101 | Final Rejection | — | Pending | Jul 31, 2023 |
| 18274979 | IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS | The Regents of the University of California | BUNNER, BRIDGET E | 1647 | §102§103§112 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18274152 | Genetically Modified Hepatocyte Populations | Cytotheryx, Inc. | YU, MISOOK | 1641 | §102§103§112 | Non-Final OA | 84d | Pending | Jul 25, 2023 |
| 18223943 | Drug Implants Containing Darolutamide and Methods of Use Thereof | Alessa Therapeutics, Inc. | WERTZ, ASHLEE ELIZABETH | 1612 | §103DP | Final Rejection | 58d overdue | Pending | Jul 19, 2023 |
| 18351367 | Autoantigens Engineered to Suppress Autoimmune Response | Adaxion Therapeutics, Inc. | ALDARONDO, DASIA ALI | 1647 | §102§103§112DP | Non-Final OA | — | Pending | Jul 12, 2023 |
| 18261083 | Linear DNA With Enhanced Resistance Against Exonucleases and Methods for the Production Thereof | 4Basebio UK Ltd. | SCHLOOP, ALLISON ELIZABETH | 1683 | §103DP | Non-Final OA | — | Pending | Jul 11, 2023 |
| 18271663 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd. | NIEBAUER, RONALD T | 1658 | §101§102§112 | Non-Final OA | 60d | Pending | Jul 10, 2023 |
| 18210515 | Magnesium Threonate Compositions and Uses Thereof | Neurocentria, Inc. | SOROUSH, LAYLA | 1622 | §103DP | Non-Final OA | — | Pending | Jun 15, 2023 |
| 18208576 | METHOD AND APPARATUS FOR REDUCING PROBABILITY OF ICE NUCLEATION DURING PRESERVATION OF BIOLOGICAL MATTER IN ISOCHORIC SYSTEMS | Biochoric, Inc. | MCCORMICK, CATHERINE LYNN | 1638 | §102§103DP | Final Rejection | — | Pending | Jun 12, 2023 |
| 18265410 | Plants With Sr2-mediated Stem Rust Resistance | Grains Research And Development Corporation | ORDAZ, CHRISTIAN JOSE | 1663 | §102§112 | Non-Final OA | 4d overdue | Pending | Jun 05, 2023 |
| 18265171 | Biliary Delivery Methods, Compositions and Kits for Use Therein | Cytotheryx, Inc. | ROSENTHAL, ANDREW S | 1613 | §103 | Final Rejection | 61d | Pending | Jun 02, 2023 |
| 18039840 | Antibody Delivery | Ac Immune SA | MCCORMICK, CATHERINE LYNN | 1638 | §102 | Final Rejection | 26d | Pending | Jun 01, 2023 |
| 18039126 | METHODS FOR USING NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS IN THE TREATMENT OF A NEUROLOGICAL CONDITION | Manzanita Pharmaceuticals, Inc. | MIKNIS, ZACHARY J | 1658 | §112 | Non-Final OA | — | Pending | May 26, 2023 |
| 18036133 | CLUBROOT RESISTANCE IN RAPESEED BRASSICA NAPUS | Npz Innovation GmbH | WILLIAMS, KEITH RICHARD | 1663 | §102§103 | Non-Final OA | 210d overdue | Pending | May 09, 2023 |
| 18034338 | NEW POLYMERASE AND USE THEREOF | Genovis AB | BOWERS, ERIN M | 1653 | §102§103§112 | Non-Final OA | — | Pending | Apr 27, 2023 |
| 18032513 | SELF-PURIFIED NUCLEIC ACID ENCODED LIBRARIES | Andreas Gloger | LAFAVE, ELIZABETH ROSE | 1684 | §102 | Non-Final OA | — | Pending | Apr 18, 2023 |
| 18020611 | TARGETED PROTEIN DEGRADATION IN THERAPEUTIC CELLS | The Regents of the University of California | BELYAVSKYI, MICHAIL A | 1644 | §103DP | Non-Final OA | 8d overdue | Pending | Feb 09, 2023 |
| 18017849 | COMBINATORIAL ANTIGEN RECOGNITION IN CANCER T CELL THERAPIES | The Simons Foundation, Inc. | PETERS, ALEC JON | 1641 | §103§112DP | Final Rejection | 20d | Pending | Jan 24, 2023 |
| 18015309 | PB2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Xizang Haisco Pharmaceutical Co., Ltd. | YOO, SUN JAE | 1621 | §102 | Final Rejection | 39d | Pending | Jan 09, 2023 |
| 18087162 | Stem Rust Resistance Gene | Commonwealth Scientific And Industrial Research Organisation | ORDAZ, CHRISTIAN JOSE | 1663 | §101§102§103§112Other | Final Rejection | — | Pending | Dec 22, 2022 |
| 17926921 | System for Localization of Anatomical Sites | The Regents of the University of California | POPESCU, GABRIEL VICTOR | 3797 | §103 | Final Rejection | 28d | Pending | Nov 21, 2022 |
| 17998641 | METHODS AND ANTIBODIES IN TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) | The Regents of the University of California | SHUPE, ELIZABETH A | 1643 | §103Other | Non-Final OA | — | Pending | Nov 11, 2022 |
| 17921739 | Methods for Generating Thymic Cells in Vitro | The Regents of the University of California | TRAN, KHOA NHAT | 1632 | §103§112 | Non-Final OA | — | Pending | Oct 27, 2022 |
| 17995058 | Methods, Compositions, and Kits for Identifying Regions of Genomic DNA Bound to a Protein | The Brigham And Women'S Hospital, Inc. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103 | Non-Final OA | 53d overdue | Pending | Sep 29, 2022 |
| 17800516 | Inhibitors of Human Herpesviruses | The Governors of the University of Alberta | ENGLISH, CONNOR KENNEDY | 1625 | §112 | Non-Final OA | — | Pending | Aug 17, 2022 |
| 17848313 | SYSTEMS AND METHODS FOR TARGETING CANCER CELLS | The Simons Foundation, Inc. | SKELDING, ZACHARY S | 1644 | §102§103 | Non-Final OA | 63d | Pending | Jun 23, 2022 |
| 17745399 | NANOPORE SENSOR FOR ENZYME-MEDIATED PROTEIN TRANSLOCATION | The Regents of the University of California | MINCHELLA, KAITLYN L | 1685 | §112DP | Final Rejection | — | Pending | May 16, 2022 |
| 17733866 | Method for Determining Relatedness of Genomic Samples Using Partial Sequence Information | The Regents of the University of California | WOITACH, JOSEPH T | 1631 | §101§103 | Non-Final OA | — | Pending | Apr 29, 2022 |
| 17769693 | NEUROTROPHIN RECEPTOR BINDING CONJUGATE COMPOSITIONS, METHODS OF USE AND METHODS OF MAKING THEREOF | Manzanita Pharmaceuticals, Inc. | SCHLIENTZ, LEAH H | 1618 | §102 | Final Rejection | 23d | Pending | Apr 15, 2022 |
| 17642089 | ANTI-ONCOLYTIC VIRUS ANTIGEN ANTIBODIES AND METHODS OF USING SAME | UVIC INDUSTRY PARTNERSHIPS INC. | PATTERSON, SARAH COOPER | 1675 | §112Other | Final Rejection | 46d | Pending | Mar 10, 2022 |
| 17633749 | Neurofeedback Training to Promote Sharp Wave Ripples | The Regents of the University of California | ORTEGA, MARTIN NATHAN | 3791 | §101 | Final Rejection | — | Pending | Feb 08, 2022 |
| 17630875 | SYNTHETIC IMMUNE CELLS AND METHODS OF USE THEREOF | The Regents of the University of California | RYAN, DOUGLAS CHARLES | 1635 | §103§112DP | Final Rejection | 74d overdue | Pending | Jan 27, 2022 |
| 17618870 | USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT | Shanghai Kechow Pharma, Inc. | MOORE, SUSANNA | 1624 | §103§112 | Final Rejection | 55d | Pending | Dec 13, 2021 |
| 17544527 | Screening for Inhibitors of Prostaglandin E Synthase 3 Useful for Treatment of Prostate Cancer | The Regents of the University of California | RYAN, DOUGLAS CHARLES | 1635 | §103 | Non-Final OA | 12d | Pending | Dec 07, 2021 |
| 17605198 | MODULATING SURVIVAL OF THERAPEUTIC CELLS AND METHODS, CELLS AND NUCLEIC ACIDS RELATED THERETO | The Regents of the University of California | MIANO, JOSEPH PAUL | 1631 | §103 | Non-Final OA | — | Pending | Oct 20, 2021 |
| 17459160 | Vibratory Expulsive Therapy For Urinary Stones | The Regents of the University of California | LEDERER, SARAH B | 3785 | §103 | Non-Final OA | 49d overdue | Pending | Aug 27, 2021 |
| 17419234 | SYNTHETIC MOLECULAR FEEDBACK CIRCUITS AND METHODS OF USING THE SAME | The Regents of the University of California | REGLAS, GILLIAN CHELSEA | 1632 | §103§112 | Final Rejection | — | Pending | Jun 28, 2021 |
| 17316153 | SUPERAGONIST POLYPEPTIDE ANALOGS OF ADRENOMEDULLIN AND INTERMEDIN PEPTIDE HORMONES | Adepthera LLC | AUDET, MAURY A | 1654 | §112 | Final Rejection | — | Pending | May 10, 2021 |
| 17282319 | Transcription Factor BRN2 Inhibitory Compounds as Therapeutics and Methods for Their Use | The University of British Columbia | VAJDA, KRISTIN ANN | 1622 | §102 | Final Rejection | — | Pending | Apr 01, 2021 |
| 17266911 | Monodispersed Particle-Triggered Droplet Formation from Stable Jets | The Regents of the University of California | THOMPSON, CURTIS A | 1798 | §103§112 | Final Rejection | — | Pending | Feb 08, 2021 |
| 17040476 | TRANS-ANTIGEN TARGETING IN HETEROGENEOUS CANCERS AND METHODS OF USE THEREOF | The Regents of the University of California | SZPERKA, MICHAEL EDWARD | 1600 | §103Other | Final Rejection | — | Pending | Sep 22, 2020 |
